Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

SELL
$1.06 - $1.67 $970 - $1,529
-916 Reduced 30.33%
2,104 $2,000
Q4 2023

Jan 31, 2024

SELL
$1.26 - $1.79 $4,970 - $7,061
-3,945 Reduced 56.64%
3,020 $5,000
Q3 2023

Nov 03, 2023

BUY
$1.61 - $2.54 $1,275 - $2,011
792 Added 12.83%
6,965 $12,000
Q2 2023

Aug 01, 2023

BUY
$1.14 - $1.95 $5,766 - $9,863
5,058 Added 453.63%
6,173 $11,000
Q1 2023

Apr 28, 2023

SELL
$1.2 - $2.19 $2,560 - $4,673
-2,134 Reduced 65.68%
1,115 $1,000
Q4 2022

Jan 27, 2023

BUY
$1.63 - $3.52 $4,712 - $10,176
2,891 Added 807.54%
3,249 $5,000
Q3 2022

Nov 08, 2022

BUY
$0.73 - $3.74 $261 - $1,338
358 New
358 $1,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.